Trial
NCT04154033
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
—
Condition
Atopic Dermatitis
Intervention
Naltrexone
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-20